<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>47</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Radovan Vasic</style></author><author><style face="normal" font="default" size="100%">Yuliang Shi</style></author><author><style face="normal" font="default" size="100%">Andrea Arruda</style></author><author><style face="normal" font="default" size="100%">Sarah Malik</style></author><author><style face="normal" font="default" size="100%">Jaime Claudio</style></author><author><style face="normal" font="default" size="100%">Jose-Mario Capo-Chichi</style></author><author><style face="normal" font="default" size="100%">Aniket Bankar</style></author><author><style face="normal" font="default" size="100%">Hassan Sibai</style></author><author><style face="normal" font="default" size="100%">Dawn Maze</style></author><author><style face="normal" font="default" size="100%">James Kennedy</style></author><author><style face="normal" font="default" size="100%">Wei Xu</style></author><author><style face="normal" font="default" size="100%">Vikas Gupta</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Significance of Emergent Leukocytosis in Patients with Myelofibrosis Receiving JAK Inhibitor Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">Blood</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1182/blood-2020-139936</style></url></web-urls></urls><pub-location><style face="normal" font="default" size="100%">2020 American Society of Hematology</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>